Connor, Clark & Lunn Investment Management (CC&L)’s Tango Therapeutics TNGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-196,384
| Closed | -$1.56M | – | 1694 |
|
|
2024
Q1 | $1.56M | Buy |
196,384
+15,786
| +9% | +$125K | 0.01% | 744 |
|
|
2023
Q4 | $1.79M | Buy |
180,598
+161,177
| +830% | +$1.6M | 0.01% | 698 |
|
|
2023
Q3 | $219K | Buy |
19,421
+7,077
| +57% | +$79.7K | ﹤0.01% | 1222 |
|
|
2023
Q2 | $41K | Buy |
+12,344
| New | +$41K | ﹤0.01% | 1276 |
|